Swiss Group for Clinical Cancer Research: Lung Neoplasms trials

The registry lists 11 Lung Neoplasms studies with Swiss Group for Clinical Cancer Research as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 8Phase 3 1No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC)TerminatedNCT03762122Phase 2
• Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC.CompletedNCT02964689Phase 1
• Early Hippocampal Avoidance Prophylactic Cranial Irradiation in Patients With LD SCLCCompletedNCT02058056Not applicable
• Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).CompletedNCT01116219Phase 2
• Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01059188Phase 2
• Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT01057342Phase 2
• Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLCCompletedNCT00354549Phase 2
• Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00217698Phase 2
• Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLCCompletedNCT00030810Phase 2
• Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC PatientsCompletedNCT00030771Phase 3
• Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung CancerCompletedNCT00003231Phase 2